Difference between revisions of "Stub"
Jump to navigation
Jump to search
| Line 13: | Line 13: | ||
====Targeted therapy==== | ====Targeted therapy==== | ||
*[[Thalidomide (Thalomid)]] | *[[Thalidomide (Thalomid)]] | ||
| + | |||
| + | ==EP, Tamoxifen, RT== | ||
| + | {| class="wikitable" style="float:right; margin-left: 5px;" | ||
| + | |- | ||
| + | |[[#top|back to top]] | ||
| + | |} | ||
| + | EP, GM-CSF, RT: '''<u>E</u>'''toposide, '''<u>P</u>'''latinol (Cisplatin), Tamoxifen, '''<u>R</u>'''adiation '''<u>T</u>'''herapy | ||
| + | ===Regimen=== | ||
| + | ====Chemotherapy==== | ||
| + | *[[Etoposide (Vepesid)]] | ||
| + | *[[Cisplatin (Platinol)]] | ||
| + | ====Hormonotherapy==== | ||
| + | *[[Tamoxifen (Nolvadex)]] | ||
| + | ====Radiotherapy==== | ||
| + | *Concurrent [[External_beam_radiotherapy|thoracic radiation therapy]] | ||
==Ixabepilone & Bevacizumab== | ==Ixabepilone & Bevacizumab== | ||
Revision as of 02:01, 30 July 2020
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon. This page is primarily to drive the Ontology.
CE & Thalidomide
| back to top |
CE & Thalidomide: Carboplatin, Etoposide, Thalidomide
Regimen
Chemotherapy
Targeted therapy
EP, Tamoxifen, RT
| back to top |
EP, GM-CSF, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy
Regimen
Chemotherapy
Hormonotherapy
Radiotherapy
- Concurrent thoracic radiation therapy
Ixabepilone & Bevacizumab
| back to top |
Regimen
Chemotherapy
Targeted therapy
TG+Bev
| back to top |
TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab
Regimen
Chemotherapy
Targeted therapy
TX+Bev
| back to top |
TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab